Anticoagulants and Antiplatelet Agents for Preventing Central Venous Haemodialysis Catheter Malfunction in Patients With End-Stage Kidney Disease - PubMed https://t.co/3XkFNEC7FG
RT @CochraneKidney: Alternative anticoagulant locking solutions reduced catheter-related #bacteraemia in #haemodialysis patients https://t.…
RT @SENefrologia: #SystematicReview - Revisión Cochrane - Anticoagulantes y antiagregantes para la disfunción de catéteres - https://t.co/4…
RT @SENefrologia: #SystematicReview - Revisión Cochrane - Anticoagulantes y antiagregantes para la disfunción de catéteres - https://t.co/4…
RT @SENefrologia: #SystematicReview - Revisión Cochrane - Anticoagulantes y antiagregantes para la disfunción de catéteres - https://t.co/4…
RT @SENefrologia: #SystematicReview - Revisión Cochrane - Anticoagulantes y antiagregantes para la disfunción de catéteres - https://t.co/4…
#SystematicReview - Revisión Cochrane - Anticoagulantes y antiagregantes para la disfunción de catéteres - https://t.co/4Si7RI5VaE
RT @CochraneKidney: Alternative anticoagulant locking solutions reduced catheter-related #bacteraemia in #haemodialysis patients https://t.…
RT @CochraneKidney: Benefit of anticoagulant therapies for preventing catheter malfunction in #haemodialysis patients remains uncertain htt…
Anticoagulants and antiplatelet agents for preventing central venous haemodialysis catheter malfunction in pat... https://t.co/IsapUNioN5
Alternative anticoagulant locking solutions reduced catheter-related #bacteraemia in #haemodialysis patients https://t.co/vYCWfW7JOl
RT @CochraneKidney: Benefit of anticoagulant therapies for preventing catheter malfunction in #haemodialysis patients remains uncertain htt…
Benefit of anticoagulant therapies for preventing catheter malfunction in #haemodialysis patients remains uncertain https://t.co/vYCWfW7JOl